I've said for years that "Alzheimer's" is actually
Post# of 1460
Quote:
Boger said too many drugmakers “barrel through” Phase II testing, instead of using those studies to explore a molecule’s best path forward. An after-the-fact data cut showed the drug appeared to be particularly effective in patients with dementia with Lewy bodies, or DLB, who didn’t show certain signs of Alzheimer’s disease. CervoMed’s next study is only recruiting this group of patients,, or “pure DLB” patients. The company expects topline results from the placebo-controlled study in the second half of 2024.
https://endpts.com/vertex-founder-joshua-boge...g-readout/